US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
TVRD holding history
Tvardi Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TVRD overviewAll 13F holders of TVRDFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −3−100.0% | Sold outConverted for a 1-for-12 split | Holders |
| Q3 2024 | 35 | $11 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 35 | $9 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 35 | $32 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 35 | $26 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 35 | $59 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 35 | $99 | <0.1% | −109−75.7% | Reduced | Holders |
| Q1 2023 | 144 | $707 | <0.1% | −118−45.0% | Reduced | Holders |
| Q4 2022 | 262 | $2.81K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 262 | $2.00K | <0.1% | +227+648.6% | Added | Holders |
| Q2 2022 | 35 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2022 | 35 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q4 2021 | 35 | $0 | 0.0% | −23−39.7% | Reduced | Holders |
| Q3 2021 | 58 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 58 | $1.00K | <0.1% | +58 | New | Holders |